chloroquine has been researched along with Kidney Failure, Chronic in 15 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a 33-year-old female patient who had hemodialysis-associated pseudoporphyria which did not respond to treatment with oral N-acetylcysteine." | 7.77 | Hemodialysis-associated pseudoporphyria resistant to N-acetylcysteine. ( Alouane, Z; Bahadi, A; El Kabbaj, D; Laalou, A; Oualim, Z, 2011) |
| "At least four doses of quinine followed by a single dose of mefloquine or by a single dose of sulfadoxine-pyrimethamine are two highly effective regimens for chloroquine-resistant falciparum malaria." | 4.75 | The treatment of malaria. ( Hall, AP, 1976) |
| "We report a 33-year-old female patient who had hemodialysis-associated pseudoporphyria which did not respond to treatment with oral N-acetylcysteine." | 3.77 | Hemodialysis-associated pseudoporphyria resistant to N-acetylcysteine. ( Alouane, Z; Bahadi, A; El Kabbaj, D; Laalou, A; Oualim, Z, 2011) |
| "The current coronavirus disease 2019 (COVID-19) pandemic requires extra attention for immunocompromised patients, including solid organ transplant recipients." | 1.56 | Severe COVID-19 in a renal transplant recipient: A focus on pharmacokinetics. ( Alwayn, IPJ; de Fijter, JW; de Vries, APJ; Janson, JA; Meziyerh, S; Moes, DJAR; Reinders, MEJ; van Etten, RW; van Gelder, T; Zwart, TC, 2020) |
| "Hypopigmentation of hair and freckles occurred in a patient receiving chloroquine sulfate therapy." | 1.27 | Chloroquine-induced hypopigmentation of hair and freckles. Association with congenital renal failure. ( Arfeux, F; Dupré, A; Ortonne, JP; Viraben, R, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (60.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Meziyerh, S | 1 |
| Zwart, TC | 1 |
| van Etten, RW | 1 |
| Janson, JA | 1 |
| van Gelder, T | 1 |
| Alwayn, IPJ | 1 |
| de Fijter, JW | 1 |
| Reinders, MEJ | 1 |
| Moes, DJAR | 1 |
| de Vries, APJ | 1 |
| El Kabbaj, D | 1 |
| Laalou, A | 1 |
| Alouane, Z | 1 |
| Bahadi, A | 1 |
| Oualim, Z | 1 |
| Müller-Höcker, J | 1 |
| Schmid, H | 1 |
| Weiss, M | 1 |
| Dendorfer, U | 1 |
| Braun, GS | 1 |
| Thorogood, N | 1 |
| Atwal, S | 1 |
| Mills, W | 1 |
| Jenner, M | 1 |
| Lewis, DA | 1 |
| Cavenagh, JD | 1 |
| Agrawal, SG | 1 |
| Sisó, A | 1 |
| Ramos-Casals, M | 1 |
| Bové, A | 1 |
| Brito-Zerón, P | 1 |
| Soria, N | 1 |
| Muñoz, S | 1 |
| Testi, A | 1 |
| Plaza, J | 1 |
| Sentís, J | 1 |
| Coca, A | 1 |
| Fabre, J | 3 |
| de Freudenreich, J | 2 |
| Duckert, A | 2 |
| Pitton, JS | 2 |
| Rudhardt, M | 2 |
| Virieux, C | 1 |
| Wirth, W | 1 |
| Diekmann, L | 1 |
| Klokenbusch, S | 1 |
| Hall, AP | 1 |
| Nampoory, MR | 1 |
| Nessim, J | 1 |
| Gupta, RK | 1 |
| Johny, KV | 1 |
| Dupré, A | 1 |
| Ortonne, JP | 1 |
| Viraben, R | 1 |
| Arfeux, F | 1 |
| Roelofs, RI | 1 |
| Engel, WK | 1 |
| Missmahl, HP | 1 |
| Higuchi, T | 1 |
1 review available for chloroquine and Kidney Failure, Chronic
| Article | Year |
|---|---|
The treatment of malaria.
Topics: Anemia; Antimalarials; Blackwater Fever; Child; Child, Preschool; Chloroquine; Coma; Drug Combinatio | 1976 |
14 other studies available for chloroquine and Kidney Failure, Chronic
| Article | Year |
|---|---|
Severe COVID-19 in a renal transplant recipient: A focus on pharmacokinetics.
Topics: Adult; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Drug Combin | 2020 |
Hemodialysis-associated pseudoporphyria resistant to N-acetylcysteine.
Topics: Acetylcysteine; Administration, Oral; Adult; Chloroquine; Drug Resistance; Female; Humans; Kidney Fa | 2011 |
Chloroquine-induced phospholipidosis of the kidney mimicking Fabry's disease: case report and review of the literature.
Topics: alpha-Galactosidase; Chloroquine; Diagnosis, Differential; Fabry Disease; Female; Humans; Hypertensi | 2003 |
The risk of antimalarials in patients with renal failure.
Topics: Adult; Anemia, Megaloblastic; Antimalarials; Chloroquine; Dermatitis, Exfoliative; Drug Therapy, Com | 2007 |
Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival.
Topics: Adolescent; Adult; Aged; Antimalarials; Biopsy; Child; Chloroquine; Disease Progression; Female; Fol | 2008 |
Influence of renal insufficiency on the excretion of chloroquine, phenobarbital, phenothiazines and methacycline.
Topics: Adult; Aged; Chloroquine; Chlorpromazine; Glomerular Filtration Rate; Humans; Kidney Failure, Chroni | 1967 |
[Problems of disseminated lupus erythematosus in infants and children].
Topics: Arthritis, Rheumatoid; Azathioprine; Child; Child, Preschool; Chloroquine; Dermatomyositis; Female; | 1978 |
Drug interaction of chloroquine with ciclosporin.
Topics: Chloroquine; Cyclosporine; Drug Interactions; Humans; Kidney Failure, Chronic; Malaria; Male; Middle | 1992 |
Chloroquine-induced hypopigmentation of hair and freckles. Association with congenital renal failure.
Topics: Adolescent; Chloroquine; Female; Hair; Hair Color; Humans; Kidney Failure, Chronic; Melanosis; Pigme | 1985 |
Myopathies associated with systemic diseases.
Topics: Alcoholism; Anti-Bacterial Agents; Chloroquine; Collagen Diseases; Endocrine System Diseases; Erythe | 1971 |
[Influence of renal insufficiency on the excretion of diverse drugs (chloroquine, sedatives, methacycline)].
Topics: Barbiturates; Chloroquine; Chlorpromazine; Creatinine; Humans; Hypnotics and Sedatives; Kidney Failu | 1966 |
[Drugs and renal function].
Topics: Biotransformation; Cephaloridine; Chloroquine; Chlortetracycline; Colistin; Creatinine; Doxycycline; | 1967 |
[Amyloidosis in ankylosing spondylitis].
Topics: Amyloidosis; Biopsy; Chloroquine; Diagnosis, Differential; Female; Humans; Kidney Failure, Chronic; | 1969 |
[Clinical observation on the course and prognosis of nephritis, including primary nephrotic syndrome. 5. Clinical treatment. 1].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Albuminuria; Chloroquine; Female; Humans; Kidney Failure | 1968 |